Riskpilot← Back to searchSign inGet full accesstand32 AB
ABActiveOrg 5593812117Norra Hamngatan 11 CHospital activities · NACE 8610Est. 20222 employees
Revenue 2025
SEK 5M
+145% vs 2024
EBITDA margin
28.9%
+29% vs 2024
Equity ratio
66.0%
Financial strength
Net profit 2025
SEK 973K
+26% vs 2024
| Revenue | SEK 5M | +145% |
| EBITDA | SEK 1,4M | +29% |
| Net profit | SEK 973K | +26% |
| Total assets | SEK 3,6M | +36% |
| Equity | SEK 2,4M | +69% |
| Employees | 2 | — |
Legal name
tand32 AB
Org number
5593812117
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
17 maj 2022
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Utför tandvård. och tandvårdstjänster, sälja och köpa tandvårdsprodukter skönhets klinik för injektionsbehandlingar och övriga hudbehandlingar sälj och köp av hudprodukter och hudbehandlingar.
Address
Norra Hamngatan 11 C
Email
aseelbahar@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 238 | 1 274 | 2 029 | 4 974 |
| Staff expenses | −70 | −12 | −357 | −1 154 |
| EBITDA | −29 | 1 004 | 1 111 | 1 436 |
| Depreciation & amort. | −66 | −142 | −139 | −209 |
| EBIT | −94 | 862 | 972 | 1 227 |
| Net financials | — | −0 | 1 | −1 |
| Profit before tax | −94 | 862 | 973 | 1 226 |
| Tax | — | −158 | −200 | −253 |
| Net profit | −94 | 704 | 772 | 973 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 728 | 1 685 | 2 661 | 3 607 |
| Equity | 31 | 734 | 1 407 | 2 380 |
| Long-term debt | 650 | 650 | 750 | 763 |
| Short-term debt | 47 | 300 | 504 | 465 |
| Total debt | 697 | 950 | 1 254 | 1 228 |
EBITDA margin
28.9%
This company
15.8%
Market median
+83% vs market
20222025
Equity ratio
66.0%
This company
38.2%
Market median
+73% vs market
20222025
Return on equity
40.9%
This company
18.4%
Market median
+122% vs market
20222025
Net profit margin
19.6%
This company
8.1%
Market median
+142% vs market
20222025
Asset turnover
1.38×
This company
1.12×
Market median
+23% vs market
20222025
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-12-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-05-17 – 2022-11-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AR Chief Executive Officer | Chief Executive Officer | 2022 |
SM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MyoDent Holding AB
tand32 AB Board members of tand32 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Aseel Riyadh Hamzah Bahr | Chief Executive Officer | 0 companies |
| Salahaldin Mehdi Sayed Al Mosawi | Deputy Chief Executive Officer | 0 companies |